The changing clinical research pathway

Read full text Summarise with VIRAT
Authors: Eva Sophie Lunde Pedersen, Karan Jatwani, Daniëlle Verschoor, A. Tardit, Eva Segelov
Cited by: 0
References: 18

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract The research landscape for breast cancer is steadily evolving. The last decade has seen major improvements in preclinical studies involving 3D models mimicking human pathology; screening and diagnosis through improved imaging; and therapeutics, including optimization of surgical techniques, hypofractionated radiation therapy, and multiple new systemic therapies. Novel clinical trial methodologies have improved possibilities for assessing effects of targeted and multiple drugs within one or more tumour subtypes, and the evolving use of real-world data has helped validate and quantify impacts of clinical trial findings into routine practice. However, trials are lacking in low-and middle-income countries, leading to increasing global disparities. Across settings and topics, patient and public involvement is now routine in breast cancer research, and evidence is accumulating of its benefit in assisting enrolment and engagement in clinical trials.

Fields of Study & Subjects

Breast Cancer Treatment Studies Ethics in Clinical Research Health and Medical Research Impacts

Publication details

Journal / source
Oxford University Press eBooks
Pages
303–313
Publication date
1 March 2026
Language
EN
Document type
Book chapter